Literature DB >> 17151835

How to select the doses of vitamin D in the management of osteoporosis.

H A Bischoff-Ferrari1.   

Abstract

The dose of vitamin D in the management of osteoporosis should be no less than 700-800 IU per day. An optimal dose of vitamin D should raise serum concentrations of 25(OH)D to the desirable range of at least 75 nmol/l. Higher intermittent oral doses of vitamin D may overcome low adherence. Vitamin D supplementation in the management of osteoporosis holds a significant public health potential because of its low cost, excellent tolerability, and combined musculo-skeletal benefits. Fall and fracture prevention with vitamin D is especially appealing in the treatment of older individuals at risk for fall-related fractures. However, bone density, strength, and function benefits with vitamin D include active and inactive subgroups of community-dwelling older men and women. Based on a recent expert panel and supportive evidence presented in this review, serum concentrations of at least 75 nmol/l 25(OH)D will be referred to as desirable. Today, desirable serum 25(OH)D levels of at least 75 nmol/l may only be reached in about one third of US older individuals and even fewer European older individuals. Two main factors discussed in this review may help public health efforts to ensure desirable vitamin D levels for fall and fracture prevention, including (1) a sufficient dose of vitamin D and (2) improved adherence to supplementation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17151835     DOI: 10.1007/s00198-006-0293-9

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  52 in total

1.  Vitamin D insufficiency among free-living healthy young adults.

Authors:  Vin Tangpricha; Elizabeth N Pearce; Tai C Chen; Michael F Holick
Journal:  Am J Med       Date:  2002-06-01       Impact factor: 4.965

2.  Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or =60 y.

Authors:  Heike A Bischoff-Ferrari; Thomas Dietrich; E John Orav; Frank B Hu; Yuqing Zhang; Elisabeth W Karlson; Bess Dawson-Hughes
Journal:  Am J Clin Nutr       Date:  2004-09       Impact factor: 7.045

3.  Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults.

Authors:  Heike A Bischoff-Ferrari; Thomas Dietrich; E John Orav; Bess Dawson-Hughes
Journal:  Am J Med       Date:  2004-05-01       Impact factor: 4.965

4.  Falls in the elderly: a prospective study of risk factors and risk profiles.

Authors:  W C Graafmans; M E Ooms; H M Hofstee; P D Bezemer; L M Bouter; P Lips
Journal:  Am J Epidemiol       Date:  1996-06-01       Impact factor: 4.897

5.  Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial.

Authors:  A M Grant; A Avenell; M K Campbell; A M McDonald; G S MacLennan; G C McPherson; F H Anderson; C Cooper; R M Francis; C Donaldson; W J Gillespie; C M Robinson; D J Torgerson; W A Wallace
Journal:  Lancet       Date:  2005 May 7-13       Impact factor: 79.321

6.  Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss.

Authors:  J C Gallagher; S E Fowler; J R Detter; S S Sherman
Journal:  J Clin Endocrinol Metab       Date:  2001-08       Impact factor: 5.958

Review 7.  Environmental factors that influence the cutaneous production of vitamin D.

Authors:  M F Holick
Journal:  Am J Clin Nutr       Date:  1995-03       Impact factor: 7.045

8.  Single-dose cholecalciferol suppresses the winter increase in parathyroid hormone concentrations in healthy older men and women: a randomized trial.

Authors:  K T Khaw; R Scragg; S Murphy
Journal:  Am J Clin Nutr       Date:  1994-05       Impact factor: 7.045

9.  Dietary calcium and hip fracture risk: the NHANES I Epidemiologic Follow-Up Study.

Authors:  A C Looker; T B Harris; J H Madans; C T Sempos
Journal:  Osteoporos Int       Date:  1993-07       Impact factor: 4.507

10.  Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  Shanna Nesby-O'Dell; Kelley S Scanlon; Mary E Cogswell; Cathleen Gillespie; Bruce W Hollis; Anne C Looker; Chris Allen; Cindy Doughertly; Elaine W Gunter; Barbara A Bowman
Journal:  Am J Clin Nutr       Date:  2002-07       Impact factor: 7.045

View more
  21 in total

1.  Osteoporosis and gastrointestinal disease.

Authors:  Seymour Katz; Stuart Weinerman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-08

2.  How much vitamin D should I take?

Authors:  Cathleen S Colón-Emeric; Kenneth W Lyles
Journal:  J Clin Invest       Date:  2012-05       Impact factor: 14.808

Review 3.  [Diagnosis of osteoporosis in geriatric patients - possibilities and limitations].

Authors:  Peter Mikosch
Journal:  Wien Med Wochenschr       Date:  2011-09-30

4.  Effect of calcium and vitamin D supplementation on bone mineral density in women aged 65-71 years: a 3-year randomized population-based trial (OSTPRE-FPS).

Authors:  M Kärkkäinen; M Tuppurainen; K Salovaara; L Sandini; T Rikkonen; J Sirola; R Honkanen; J Jurvelin; E Alhava; H Kröger
Journal:  Osteoporos Int       Date:  2010-03-04       Impact factor: 4.507

Review 5.  Bone health in multiple sclerosis.

Authors:  J C Gibson; G D Summers
Journal:  Osteoporos Int       Date:  2011-05-21       Impact factor: 4.507

6.  The effect of high-dose vitamin D on bone mineral density and bone turnover markers in postmenopausal women with low bone mass--a randomized controlled 1-year trial.

Authors:  G Grimnes; R Joakimsen; Y Figenschau; P A Torjesen; B Almås; R Jorde
Journal:  Osteoporos Int       Date:  2011-09-10       Impact factor: 4.507

7.  Efficacy of different doses and time intervals of oral vitamin D supplementation with or without calcium in elderly nursing home residents.

Authors:  V Chel; H A H Wijnhoven; J H Smit; M Ooms; P Lips
Journal:  Osteoporos Int       Date:  2007-09-14       Impact factor: 4.507

8.  Rapid correction of low vitamin D status in nursing home residents.

Authors:  R Przybelski; S Agrawal; D Krueger; J A Engelke; F Walbrun; N Binkley
Journal:  Osteoporos Int       Date:  2008-04-18       Impact factor: 4.507

Review 9.  Drug Insight: choosing a drug treatment strategy for women with osteoporosis-an evidence--based clinical perspective.

Authors:  Piet P Geusens; Christian H Roux; David M Reid; Willem F Lems; Silvano Adami; Jonathan D Adachi; Philip N Sambrook; Kenneth G Saag; Nancy E Lane; Marc C Hochberg
Journal:  Nat Clin Pract Rheumatol       Date:  2008-04-08

Review 10.  Progress in osteoporosis and fracture prevention: focus on postmenopausal women.

Authors:  Kenneth G Saag; Piet Geusens
Journal:  Arthritis Res Ther       Date:  2009-10-14       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.